Healthcare -
Biotechnology - NASDAQ - US
$ 1.98
-1.01 %
$ 147 M
Market Cap
-3.38
P/E
IKT - OPERATING EXPENSES
Operating Expenses IKT - Inhibikase Therapeutics, Inc.
28.6 M
LAST VALUE
25.52%
2 YEAR CAGR
38.04%
5 YEAR CAGR
0.00%
10 YEAR CAGR